Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma

被引:0
作者
Lo Muzi, L
Leonardi, R
Mignogna, MD
Pannone, G
Rubini, C
Pieramici, T
Trevisiol, L
Ferrari, F
Serpico, R
Testa, N
De Rosa, G
Staibano, S
机构
[1] Univ Ancona, Inst Dent Sci, Ancona, Italy
[2] Univ Ancona, Inst Pathol Anat, Ancona, Italy
[3] Catania Univ, Dept Med & Surg Sci, Dent Unity 2, Catania, Italy
[4] Univ Naples Federico II, Dept Dent Sci, Pathol Unity, Naples, Italy
[5] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Pathol Unity, Naples, Italy
[6] Univ Verona, Inst Dent Sci, I-37100 Verona, Italy
[7] Univ Bari, Dept Dent Sci & Surg, Bari, Italy
关键词
c-Met; oral squamous cell carcinoma; oral mucosa; metastasis; growth factor receptor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This report was performed to study the biological role of c-Met in oral tumorigenesis by analyzing its expression in relation to clinicopathological features. Seventy-three cases of oral squamous cell carcinoma and 10 of normal mucosa were analysed for c-Met expression by immunohistochemistry. Normal oral squamous epithelium showed absent or low membranous positivity in the intermediate (malpighian - spinous) layer. Fifty-seven cases (78%) of carcinoma showed immunopositivity, with a prevalently membranous positivity and scattered areas also showing a cytoplasmic localization. Sixteen cases of carcinoma (22%) showed no positivity for c-Met. Among positive tumours, well-differentiated areas showed low or absent cytoplasmic positivity, while low-differentiated areas showed both membranous and cytoplasmic positivity. There was no statistically significant correlation between c-Met expression and sex, recurrence, staging or grading. The frequency of lymph node metastases was higher in c-Met-positive tumours (17/57, 29%) than in c-Met-negative ones (4/16, 25%). When analysed for prognostic significance, patients with negative/reduced c-Met expression had better survival rates than patients with high expression. The difference between survival rates was statistically significant (p < 0.05). These data suggest that c-Met expression may be useful to identify cases of oral squamous cell carcinoma with a more aggressive and invasive phenotype.
引用
收藏
页码:1063 / 1069
页数:7
相关论文
共 36 条
[1]   Invasive-growth signaling by the Met/HGF receptor -: The hereditary renal carcinoma connection [J].
Bardelli, A ;
Pugliese, L ;
Comoglio, PM .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (03) :M41-M51
[2]   Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase [J].
Birchmeier, C ;
Gherardi, E .
TRENDS IN CELL BIOLOGY, 1998, 8 (10) :404-410
[3]   ESSENTIAL ROLE FOR THE C-MET RECEPTOR IN THE MIGRATION OF MYOGENIC PRECURSOR CELLS INTO THE LIMB BUD [J].
BLADT, F ;
RIETHMACHER, D ;
ISENMANN, S ;
AGUZZI, A ;
BIRCHMEIER, C .
NATURE, 1995, 376 (6543) :768-771
[4]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[5]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[6]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[7]  
Cortesina G, 2000, INT J CANCER, V89, P286, DOI 10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO
[8]  
2-U
[9]   Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas [J].
Di Renzo, MF ;
Olivero, M ;
Martone, T ;
Maffe, A ;
Maggiora, P ;
De Stefani, A ;
Valente, G ;
Giordano, S ;
Cortesina, G ;
Comoglio, PM .
ONCOGENE, 2000, 19 (12) :1547-1555
[10]  
DIRENZO MF, 1991, ONCOGENE, V6, P1997